Eventide Asset Management, LLC Kymera Therapeutics, Inc. Transaction History
Eventide Asset Management, LLC
- $5.26 Billion
- Q2 2025
A detailed history of Eventide Asset Management, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 562,990 shares of KYMR stock, worth $34.6 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
562,990
Previous 525,138
7.21%
Holding current value
$34.6 Million
Previous $14.4 Million
70.93%
% of portfolio
0.47%
Previous 0.31%
Shares
6 transactions
Others Institutions Holding KYMR
# of Institutions
222Shares Held
72.3MCall Options Held
178KPut Options Held
64.6K-
Price T Rowe Associates Inc Baltimore, MD6.86MShares$421 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.65MShares$409 Million2.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.56MShares$403 Million5.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$345 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.5MShares$338 Million9.44% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $3.36B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...